Clinically-documented targeted probiotics for vaginal health
Women’s health is a top concern for consumers which has lead dietary supplement sales for this category to consistently grow over the years. One of the main health issues women face is vaginal infections, the most common types being bacterial vaginosis and vulvovaginal candidiasis. Since a healthy human vagina is colonized predominantly with members of the genus Lactobacillus, a reduced proportion of lactobacilli in the vaginal microbiota is associated with disease or increased disease risk.
Supplementation with probiotics is an attractive approach to increasing the levels of vaginal lactobacilli and helping reduce the risk of vaginal infections. HOWARU® Feminine Health combines Lactobacillus rhamnosusHN001™ and Lactobacillus acidophilus La-14® in a clinically proven formula to promote vaginal microbiota in addition to having beneficial effects in regards to bacterial vaginosis and vulvovaginal candidiasis.